Crossmark Global Holdings, Inc. Inari Medical, Inc. Transaction History

Crossmark Global Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$48.3 - $68.06 $16,566 - $23,344	-343 Reduced 8.6%	3,645 $237,000
Q3 2023 Nov 08, 2023	SELL	$54.2 - $71.67 $8,997 - $11,897	-166 Reduced 4.0%	3,988 $269,000
Q2 2023 Jul 31, 2023	SELL	$56.23 - $71.17 $3,092 - $3,914	-55 Reduced 1.31%	4,154 $241,000
Q1 2023 May 12, 2023	BUY	$53.43 - $68.12 $8,548 - $10,899	160 Added 3.95%	4,209 $260,000
Q4 2022 Jan 19, 2023	BUY	$61.23 - $83.62 $14,021 - $19,148	229 Added 5.99%	4,049 $257,000
Q3 2022 Nov 01, 2022	BUY	$65.58 - $84.69 $250,515 - $323,515	3,820 New	3,820 $277,000

261

56.2M

90.4K

27.3K

Ticker NARI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,389,700
Market Cap $2.96B
Description
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.